Table 1 Demographics and clinical treatment characteristics in study group.
|  | Mean ± std. error (range) (N = 146) |
|---|---|
Age (years) | 35.02 ± 2.53 (21–40) |
G (Gravida) | 0.13 ± 0.46 (0–3) |
P (Para) | 0.04 ± 0.23 (0–2) |
Weight (kg) | 62.63 ± 11.50 (45–110) |
Height (cm) | 163.00 ± 6.54 (145–180) |
Body Mass Index | 23.58 ± 4.07 (17–37) |
Baseline LH (IU/l) | 5.56 ± 2.674 (0.8–22) |
Baseline E2 (pmol/l) | 153.30 ± 53.57 (27–268) |
Baseline FSH (IU/l) | 7.29 ± 2.86 (2.6–18.5) |
Antral Follicle Count (AFC) | 12.87 ± 0.59 (3–30) |
Duration of stimulation (days) | 9.27 ± 1.90 (6–15) |
Day 2 estradiol concentration (pmol/l) | 153.30 ± 58.81 (27–268) |
Day 3 estradiol concentration (pmol/l) | 698.76 ± 369.75 (27–1529) |
Day 3/Day 2 estradiol ratio | 4.68 ± 2.41 (1–12.6) |
Day 2 LH concentration (IU/l) | 7.22 ± 2.77 (0.4–19.6) |
Day 3 LH concentration (IU/l) | 52.44 ± 19.62 (7.5–120) |
Day 3/Day 2 LH ratio | 9.17 ± 19.16 (1.42–236.75) |
Total amount of gonadotropins (IU) | 2757.25 ± 984.66 (1050–6600) |
Gonadotropin dose per day (IU) | 296.29 ± 74.47 (137.5–450) |
E2 at trigger (pmol/l) | 11,214.27 ± 7769.79 (1430–48,963) |
Progesterone at trigger (pmol/l) | 2.86 ± 1.78 (0.3–9.67) |
LH at trigger (IU/l) | 2.54 ± 9.62 (0.2–4.93) |
FSH at trigger (IU/l) | 21.01 ± 7.38 (7.9–47.5) |
M1 oocytes no | 1.03 ± 1.21 (0–5) |
M2 oocytes no | 11.10 ± 8.16 (0–48) |
GV oocytes no | 1.54 ± 2.17 (0–11) |
Total no. oocytes | 13.68 ± 9.48 (0–58) |
